drugset / Trial / NCT04910464

Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis

NCT04910464

Phase 3 Recruiting 80 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study, our aim is to investigate the role tranexamic acid in modulating inflammation in patients with sepsis.

Timeline

Start
2021-06-05
Primary completion
2027-01-10
Completion
2027-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous